Skip to main content
OpenTrials
Completed

NCT Number: NCT05019144

Telemedicine Optimized Burn Intervention

Because burn patients and their caregivers often live long distances from regional burn centers, access to expert burn care is limited, resulting in a negative effect on adherence to treatment and a higher risk of wound complication. A novel smartphone application synchronized with a web portal for providers, called the Telemedicine Optimized Burn Intervention (TOBI), was recently developed to enable burn experts to direct burn wound care while the patient and caregiver are home through text messaging, image transfer, and video-conferencing. The goal of the present study is evaluate TOBI compared to face-to-face care as usual for pediatric patients/caregivers visiting a burn center. This study will also assess the feasibility of conducting a larger-scale clinical trial in several burn centers. The app will allow the physician and patient/caregivers to make instant decisions regarding treatment, allowing for "turn on a dime" treatment decisions, rather than having the patients and families wait for scheduled clinic appointments, often hours away from home. This "on demand" medical care takes an innovative approach to increasing access to burn experts through smartphone technology and addressing adherence to prescribed treatment by increasing communication between provider and patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

0 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Caregiver parents and their children (patients) will be considered as participants and will be eligible for enrollment if:

  • the patient (child) is < 18 years of age; caregiver age >18 years of age
  • the patient is diagnosed with a partial thickness burn between <1% TBSA - 20% TBSA by a pediatric burn surgeon;
  • the patient's burn is being treated with advanced burn dressing therapy (e.g., Silvadene™, Polysporin™, Acticoat™, Mepilex™, or Mepitel™);
  • the patient's burn is evaluated by the MUSC burn team within 48 hours of injury;
  • the patient's caregiver (parent or legal guardian) is able to speak, hear, and understand English, as determined during study recruitment procedures;
  • the caregiver owns and is capable of using a smart device (an Android or iOS smartphone) with permission to download TOBI app from the Google Store or AppStore;
  • able to comply with outpatient clinic visits.

Exclusion criteria

  • There are no exclusion criteria. All participants who meet inclusion criteria would be eligible to participate in the study.

Treatment and study plan

Face-to-face burn care

Procedure

If the participants are assigned to FTF care, they will receive standard burn care including a return follow-up in the burn clinic on a routine basis as prescribed by the clinical burn team (at least once per week) until the burn has healed.

Telemedicine enhanced burn care

Procedure

Participants assigned to TOBI will be given instructions how to download and use TOBI on a smartphone, including how to interface with burn clinicians using text-messaging, videoconferencing, and sending photos of the child's burn(s). The participants will have scheduled video visits with the care provider at least weekly until the burn has healed. The participants will be able to use other features of the app, such as text-messaging and sending photos of the burn(s), as needed. The participants will be able to use standard FTF burn care as well. They will be given instructions how to contact the burn team through the hospital paging operator if TOBI is unavailable or there is an emergency.

Primary outcomes

  1. Number of Participants Who Agree to Participate in the Study

    Time frame: At enrollment

    Looking at the number of participants (parents and children) who agree to enroll in the study at the time of burn injury versus the total number of participants who were approached to participate in the study.

  2. Number of Participants Retained in the Study Over Time

    Time frame: From enrollment to 30 days after burn wound has healed (up to 35 days after enrollment).

    Looking at the number of participants retained in the study versus those lost to attrition

  3. Wound Care Treatment Adherence

    Time frame: Assessed weekly at clinic/telemedicine visit until burn wound was healed, up to 35 days after injury

    Looking at the percentage of patient/caregiver dyads who adhered to prescribed burn wound care treatment protocol. A wound care fidelity checklist was used at each visit to determine the percentage of wound care adherence per visit. These percentages were then averaged for each weekly visit to give the value below.

  4. Number of Child Participants That Experienced Adverse Events, Serious Adverse Events, and Unexpected Problems

    Time frame: Assessed weekly until burn wound was healed, up to 35 days

    Looking at the number of child participants in each condition that experienced adverse events, serious adverse events, and unexpected problems. Adverse events in this study included infection, delay in wound care or non-healing wound. Adult caregivers are not included in this as they did not have burn wounds that were assesssed.

  5. Number of Times Problems With Technology Happened in the TOBI Condition

    Time frame: Assessed weekly until burn wound was healed, up to 35 days

    Looking at the number of times providers or participants experienced and reported technological problems with TOBI

Secondary outcomes

  1. Number of Days Until Wound is Healed

    Time frame: Measured during the treatment phase (2-4 weeks)

    Looking at the number of days it takes for wound to heal following burn injury in both conditions

  2. Number of Unscheduled ED or Clinic Visits

    Time frame: Measured during the treatment phase (2-4 weeks)

    Looking at the number of times participants had unscheduled visits (in the ED or the clinic)

  3. Number of Wound Complications

    Time frame: Measured during the treatment phase (2-4 weeks)

    Looking at the number of wound complications (e.g., infection, conversion to deeper burn requiring surgery, conversion to deeper burn requiring a change in therapy).

  4. Patient-reported Pain Scores

    Time frame: Measured during the treatment phase (week 1 clinic visit)

    Looking at average pain score at follow up visits between the two groups using the Wong-Baker Scale (0-10, with higher scores = more pain). Most patients only attended one follow up visit but if more than one, the average score is reported below.

  5. Caregiver's Perception of Child's Pain Scores

    Time frame: Measured during the treatment phase (week 1 clinic visit)

    Looking at average caregiver's perception of child's pain score at follow up visits between the two groups using the Wong-Baker Scale (0-10, with higher scores = more pain). Most dyads only attended one follow up visit but if more than one, the average score is reported below.

  6. Attitudes Towards Technology and Telemedicine Questionnaire

    Time frame: Measured at baseline and 1-month follow-up

    Looking at the change in group average scores on the Attitudes Towards Technology and Telemedicine Questionnaire (caregiver-reported) from baseline to 1 month follow-up. Scores may range between 26-130, with higher scores = more positive attitudes towards technology and telemedicine.

  7. Perception of Healthcare Access

    Time frame: Measured at baseline and 1-month follow-up

    Looking at the change in group average scores on the Barriers to Care Questionnaire (BCQ), Pragmatics Subscale (caregiver-reported). Scores range from 0-100, with higher scores = fewer barriers and problems with access.

  8. Positive And Negative Affect Schedule (PANAS) Scores

    Time frame: Measured at baseline/enrollment and 1-month follow-up.

    Looking at the group average scores on the PANAS questionnaire measuring positive and negative affect (caregiver-reported). The means of the positive and negative scores for PANAS are reported below along with standard deviations. The scores range between 10-50, with higher scores = higher levels of affect (both positive and negative). For positive affect, a higher score is a better outcome and for negative affect, a lower score is a better outcome. Scores are reported for baseline and 1 month after burn wound healing.

  9. Patient-Reported Outcomes Measurement Information System - Depression (PROMIS-Depression) Scores

    Time frame: Measured at baseline and 1-month follow-up

    Looking at the baseline and 1-month follow up scores on the Patient-Reported Outcomes Measurement Information System (PROMIS)-Depression questionnaire (caregiver-reported). Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression. The raw scores on the 8 items should be summed to obtain a total raw score. Next, the T-score table is used to identify the T-score associated with the individual's total raw score. The mean T-scores is 50 with a standard deviation of 10. T-scores range between 37.1-81.1. T scores are interpreted as follows: <55 (none to slight depression), 55-59.9 (mild depression), 60-69.9 (moderate depression), >70 (severe depression). T scores and standard error are reported below.

  10. Patient-Reported Outcomes Measurement Information System - Anxiety (PROMIS-Anxiety) Scores

    Time frame: Measured at baseline and 1-month follow-up

    Looking at the baseline and 1-month follow up scores on the Patient-Reported Outcomes Measurement Information System (PROMIS)-Anxiety questionnaire (caregiver-reported). Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) range in score from 7 to 35 with higher scores indicating greater severity of anxiety. The raw scores on the 7 items should be summed to obtain a total raw score. Next, the T-score table is used to identify the T-score associated with the individual's total raw score. The mean T-scores is 50 with a standard deviation of 10. T-scores range between 36.3-82.7. T scores are interpreted as follows: <55 (none to slight anxiety), 55-59.9 (mild anxiety), 60-69.9 (moderate anxiety), >70 (severe anxiety). T scores and standard error are reported below.

  11. Patient-Reported Outcomes Measurement Information System - General Self-Efficacy (PROMIS-General-Self-Efficacy) Scores

    Time frame: Measured at baseline only

    Looking at the baseline and 1-month follow up scores on the Patient-Reported Outcomes Measurement Information System (PROMIS)-General Self Efficacy questionnaire (caregiver-reported). Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) range in score from 8 to 40 with higher scores indicating greater self efficacy. The raw scores on the 7 items should be summed to obtain a total raw score. Next, the T-score table is used to identify the T-score associated with the individual's total raw score. The mean T-scores is 50 with a standard deviation of 10. T-scores range between 22.72-64.98. A T-score value of 55 indicated that the respondent has greater self-efficacy for managing emotions. Higher scores indicating more self efficacy and lower scores with less self efficacy. T scores and standard error are reported below.

  12. Patient-Reported Outcomes Measurement Information System - Self-Efficacy to Manage Emotions (PROMIS-Self-Efficacy-Manage-Emotions) Scores

    Time frame: Measured at baseline only

    Looking at the baseline and 1-month follow up scores on the Patient-Reported Outcomes Measurement Information System (PROMIS)-Self-Efficacy Managing emotions questionnaire (caregiver-reported). Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) range in score from 4-20 with higher scores indicating greater severity of anxiety. The raw scores on the 4 items should be summed to obtain a total raw score. Next, the T-score table is used to identify the T-score associated with the individual's total raw score. The mean T-scores is 50 with a standard deviation of 10. T-scores range between 36.3-82.7. A T-score of 55 and greater indicates that the respondent has greater self efficacy and ability to manage their emotions regarding disease. A higher score than 55 indicates even more self efficacy and lower score, less. T scores and standard error are reported below.

  13. Peritraumatic Distress Inventory (PDI) Sores

    Time frame: Measured at baseline only

    Looking at average scores on the Peritraumatic Distress Inventory (caregiver-reported). Scores range between 0-52, with higher scores = greater peritraumatic distress. An optimal cutoff score of 23 (sensitivity = 71%; specificity = 73%) is good for predicting clinically elevated PTSD 30-days post-injury.

  14. Perceived Stress Scale (PSS) Scores

    Time frame: Measured at 1-month follow-up only

    Looking at average scores on the Perceived Stress Scale (caregiver-reported) between two conditions. Scores on the PSS can range from 0 to 40 with higher scores = higher perceived stress. Scores ranging from 0-13 would be considered low stress. Scores ranging from 14-26 would be considered moderate stress. Scores ranging from 27-40 would be considered high perceived stress.

  15. Posttraumatic Growth Inventory (PTGI) Scores

    Time frame: Measured at 1-month follow-up only

    Average scores on the Posttraumatic Growth Inventory (caregiver-reported). Scores range from 0-105, with higher scores = greater posttraumatic growth.

  16. Client Satisfaction Questionnaire-8 (CSQ-8) Scores

    Time frame: Measured at 1-month follow-up only

    Looking at average scores on the Client Satisfaction Questionnaire-8 scores (caregiver-reported). Scores range between 8-32, with higher scores = greater satisfaction.

  17. mHealth App Usability Questionnaire (MAUQ) Scores

    Time frame: Measured at 1-month follow-up only

    Looking at average scores on the MAUQ questionnaire measuring app usability (caregiver-reported in TOBI condition only). Raw scores range between 21-147 and average scores range between 1-7, with higher overall score equivalent to higher usability of the app. The average scores and standard deviation are reported below for the TOBI group.

  18. Total Number of Face-to-face Visits

    Time frame: Treatment phase (weeks 2-4)

    Looking at the total number of face-to-face visits

  19. Total Number of TOBI Visits

    Time frame: Treatment phase (weeks 2-4)

    Looking at the total number of TOBI visits

  20. Total Travel Time

    Time frame: From enrollment through treatment phase (weeks 1-4)

    Looking at the total travel time in each condition as reported by the caregiver.

  21. Direct Cost to Patient/Caregiver

    Time frame: From enrollment through treatment phase (weeks 1-4)

    Looking at the direct cost to patient/caregiver as reported by caregiver

  22. Time to Return to Work

    Time frame: From enrollment through the treatment phase (weeks 1-4). This included any time that the parent had was out of work because of the injury at time of occurrence or due to clinic follow up.

    Looking at the average time it took patient/caregiver to return to work after burn wound injury.

Sponsors and collaborators

Lead sponsor

Medical University of South Carolina

Other

Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Registry information

Official study title

A Novel Telemedicine Optimized Burn Intervention (TOBI) for Pediatric Burn-injured Patients and Their Caregivers

Acronym: TOBI

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Aug 24, 2021
Registry last updated
Jul 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.